Dr Pavan Bhargava gives insights on earlier diagnosis, ocrelizumab safety in pregnancy, and promising anti-aging effects of diet in RRMS.

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently diagnosed with Parkinson’s Disease ...

In 2006, Casarett published a case report in the AMA Journal of Ethics describing a patient with lung cancer who experienced a series of hospitalizations, including for febrile neutropenia, a common ...

Aaron Holley, MD, writes that it takes a 'physiologic village' to create activity intolerance after pulmonary embolism, and argues for more use of cardiopulmonary exercise testing to evaluate it.

Dr Nicholas Silvestri reports that the 2025 AAN meeting highlighted significant advances in myasthenia gravis, including improved diagnostics and emerging therapies.

Research on the gut microbiome has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease.

Imbalances in oral microbiota and poor oral health are associated with increased migraines and body pain in women with central sensitization disorders, a new study shows.

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain following bariatric surgery, a Swiss real-world study reveals.

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Only half of patients showed clinical improvement attributed to the medication, but only one new complication occurred.

Severe postpartum haemorrhage in women with grade 3 placenta accreta spectrum demonstrates significantly better outcomes in Italy than in the United Kingdom and France.